This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,653.97 firm fixed-price delivery order is for the supply of ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The award has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $4,820.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a performance period extending through April 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award, valued at $19,899.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a completion date of May 4, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a specific set-aside designation, indicating open...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - ONFI 2.5 MG/ML SUSPENSION 120ML. The contract has a ceiling value of $7,004.83 and a period of performance through April 15, 2024. This delivery order is part of a larger indefinite delivery contract between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,484.83 firm-fixed-price delivery order is for the supply of 4565633265 ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a completion date of August 30, 2024. This award is not set aside for any specific business type. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $4,384.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4566415501 ONFI 2.5 MG/ML SUSPENSION 120ML, with a firm fixed price and an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a ceiling value of $2,685.95 and a period of performance through January 9, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside....
This federal contract award, valued at $6,059.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568235910 - ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,536.00, is for the delivery of ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,408.40, is for the delivery of ONFI 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order contract. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999...